Table 1.
Summary characteristics of subjects who underwent hrHPV and Pap co-testing
| Age (years) | 56.3 ± 8.8 |
|---|---|
| Aged 21–29 years | 11 (0.7) |
| Aged 30–65 years | 1276 (86.1) |
| Aged >65 years | 194 (13.2) |
| Cervicitis/NILM | 1234 (83.3) |
| ASC-US | 58 (3.9) |
| LSIL | 112 (7.6) |
| HSIL | 75 (5.1) |
| SCC | 2 (0.1) |
| Cervical condyloma | 57 (3.8) |
| Cervical polyp | 8 (0.5) |
| Single hrHPV infection | 1144 (77.2) |
| Dual hrHPV infection | 278 (18.8) |
| Infection with three or more strains | 60 (4.0) |
NILM, negative for intraepithelial lesion or malignancy; ASC-US, atypical squamous cells of undetermined significance; LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial lesion; SCC, squamous-cell carcinoma.
Age is shown as the mean ± standard deviation; the remaining data are frequencies (percentages).